Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marathon Digital Holdings Inc (MARA) vs Philip Morris International Inc. (PM) Price & Performance

Marathon Digital Holdings IncTrade
Philip Morris International Inc.Trade

Price performance (Past 24H)

Key statistics

Marathon Digital Holdings Inc vs Philip Morris International Inc. — how do they compare? Marathon Digital Holdings Inc trades at $10.07 (market cap $4.00B), while Philip Morris International Inc. trades at $200.2 (market cap $300.33B). The key difference: Philip Morris International Inc. is far larger — about 75.1× Marathon Digital Holdings Inc's market cap, and Philip Morris International Inc. pays a 3.32% dividend while Marathon Digital Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marathon Digital Holdings Inc for 22 Days and Philip Morris International Inc. for 85 Days on average.

MARAPM
Market Cap
$4.00B$300.33B
Volume
36,668,5733,935,700
Sector
FinancialsConsumer Staples
52-Week High
$22.84$200.50
52-Week Low
$6.73$144.33
Typical Hold Time
22 Days85 Days
Enterprise Value
$6.05B$343.44B
Dividend Yield
—3.32%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marathon Digital Holdings Inc

MARA Holdings trades at $10.36, down 5.56% on the day, showing bearish technical momentum despite analyst optimism. The company faces significant fundamental challenges with a net income margin of -429.71% and consecutive quarterly earnings misses. Recent news highlights volatility tied to Bitcoin-related sentiment, though the stock remains a focus of institutional interest with 45% of analysts maintaining buy ratings and a $13.25 consensus price target suggesting 28% upside potential.

While analyst consensus points to potential appreciation, MARA's deteriorating profitability and negative cash flow from operations present substantial risks. Investors must weigh the bullish price targets against the company's persistent losses and high volatility exposure. The stock's performance remains heavily influenced by sector-wide crypto sentiment rather than standalone financial strength.

Philip Morris International Inc.

Philip Morris International (PM) trades at $200.5, up 5.3% over 24 hours, with a bullish technical signal and strong earnings beats in Q1 and Q2 2026. The company shows robust fundamentals with 2025 revenue of $40.65B and net income of $11.35B, supported by a 67.48% gross margin. Recent news highlights expansion of smoke-free products like ZYN and IQOS, now over 40% of revenue, driving growth amid industry shifts.

Outlook is positive with analyst consensus at Buy (68%) and a $212.17 price target, though elevated P/E of 26.46 and regulatory risks in tobacco remain concerns. Earnings growth and smoke-free product adoption are key catalysts, but investors should monitor debt levels and competitive pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MARA
99% Buy1% Sell
Avg holding period · 22 Days
PM
10% Buy90% Sell
Avg holding period · 85 Days

Top news

Latest headlines on both assets

About Marathon Digital Holdings Inc

Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.

Read more on MARA →

About Philip Morris International Inc.

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Read more on PM →